TransMedics Group, Inc. (TMDX)
67.12
+0.22
(+0.33%)
USD |
NASDAQ |
Oct 29, 16:00
67.50
+0.38
(+0.57%)
After-Hours: 07:42
TransMedics Group Market Cap : 2.324B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 2.324B |
| October 28, 2026 | 2.317B |
| October 27, 2026 | 2.415B |
| October 26, 2026 | 2.446B |
| October 23, 2026 | 2.450B |
| October 22, 2026 | 2.495B |
| October 21, 2026 | 2.507B |
| October 20, 2026 | 2.589B |
| October 19, 2026 | 2.479B |
| October 16, 2026 | 2.451B |
| October 15, 2026 | 2.650B |
| October 14, 2026 | 2.615B |
| October 13, 2026 | 2.740B |
| October 12, 2026 | 2.707B |
| October 09, 2026 | 2.697B |
| October 08, 2026 | 2.736B |
| October 07, 2026 | 2.807B |
| October 06, 2026 | 2.780B |
| October 05, 2026 | 2.874B |
| October 02, 2026 | 2.763B |
| October 01, 2026 | 2.723B |
| September 30, 2026 | 2.890B |
| September 29, 2026 | 2.911B |
| September 28, 2026 | 2.865B |
| September 25, 2026 | 2.954B |
| Date | Value |
|---|---|
| September 24, 2026 | 2.905B |
| September 23, 2026 | 3.013B |
| September 22, 2026 | 3.050B |
| September 21, 2026 | 3.023B |
| September 18, 2026 | 2.993B |
| September 17, 2026 | 3.001B |
| September 16, 2026 | 3.032B |
| September 15, 2026 | 3.051B |
| September 14, 2026 | 2.973B |
| September 11, 2026 | 2.846B |
| September 10, 2026 | 2.945B |
| September 09, 2026 | 2.992B |
| September 08, 2026 | 3.057B |
| September 04, 2026 | 3.116B |
| September 03, 2026 | 3.012B |
| September 02, 2026 | 2.919B |
| September 01, 2026 | 2.848B |
| August 31, 2026 | 2.939B |
| August 28, 2026 | 3.062B |
| August 27, 2026 | 3.177B |
| August 26, 2026 | 3.194B |
| August 25, 2026 | 3.241B |
| August 24, 2026 | 3.241B |
| August 21, 2026 | 3.282B |
| August 20, 2026 | 3.146B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 61.76B |
| Abbott Laboratories | 180.95B |
| Alphatec Holdings, Inc. | 1.736B |
| Baxter International, Inc. | 12.15B |
| Becton, Dickinson & Co. | 54.03B |
Market Cap Related Metrics
| PE Ratio | 17.46 |
| PS Ratio | 3.981 |
| PEG Ratio | 0.1768 |
| Price to Book Value | 4.487 |
| Price to Free Cash Flow | 33.67 |
| Price | 67.12 |
| Earnings Yield | 5.73% |
| PEGY Ratio | 0.1768 |
| Operating PE Ratio | 32.61 |
| Normalized PE Ratio | 17.46 |